Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia

por Patnaik, M M, Tefferi, A
Publicado 2016

P1323: PREDICTION OF NON-RELAPSE MORTALITY BY EASIX AND HCT-CI SCORES IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT

por Baranwal, A., Mangaonkar, A., Shah, M., Litzow, M., Hogan, W., Patnaik, M., Alkhateeb, H.
Publicado 2022

Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set

por Goyal, G, Bartley, A C, Patnaik, M M, Litzow, M R, Al-Kali, A, Go, R S
Publicado 2017

Monosomal karyotype in Philadelphia chromosome-negative acute lymphoblastic leukemia

por Kenderian, S S, Al-Kali, A, Gangat, N, Letendre, L, Hogan, W J, Litzow, M R, Patnaik, M M
Publicado 2013

Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia

por Patnaik, M M, Lasho, T L, Vijayvargiya, P, Finke, C M, Hanson, C A, Ketterling, R P, Gangat, N, Tefferi, A
Publicado 2016

Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis

por Tefferi, A, Al-Kali, A, Begna, K H, Patnaik, M M, Lasho, T L, Rizo, A, Wan, Y, Hanson, C A
Publicado 2016

Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia

por Lasho, T L, Finke, C M, Zblewski, D, Patnaik, M, Ketterling, R P, Chen, D, Hanson, C A, Tefferi, A, Pardanani, A
Publicado 2015

Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance

por Patnaik, M M, Zahid, M F, Lasho, T L, Finke, C, Ketterling, R L, Gangat, N, Robertson, K D, Hanson, C A, Tefferi, A
Publicado 2016

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML

por Laborde, R R, Patnaik, M M, Lasho, T L, Finke, C M, Hanson, C A, Knudson, R A, Ketterling, R P, Pardanani, A, Tefferi, A
Publicado 2013

Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment

por Gangat, N, Patnaik, M M, Begna, K, Al-Kali, A, Litzow, M R, Ketterling, R P, Hanson, C A, Pardanani, A D, Tefferi, A
Publicado 2016

Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis

por Patnaik, M M, Timm, M M, Vallapureddy, R, Lasho, T L, Ketterling, R P, Gangat, N, Shi, M, Tefferi, A, Solary, E, Reichard, K K, Jevremovic, D
Publicado 2017

Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients

por Saeed, L, Patnaik, M M, Begna, K H, Al-Kali, A, Litzow, M R, Hanson, C A, Ketterling, R P, Porrata, L F, Pardanani, A, Gangat, N, Tefferi, A
Publicado 2017

ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26

por Perez Botero, J, Oliveira, J L, Chen, D, Reichard, K K, Viswanatha, D S, Nguyen, P L, Pruthi, R K, Majerus, J, Gada, P, Gangat, N, Tefferi, A, Patnaik, M M
Publicado 2015

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

por Patnaik, M M, Wassie, E A, Padron, E, Onida, F, Itzykson, R, Lasho, T L, Kosmider, O, Finke, C M, Hanson, C A, Ketterling, R P, Komrokji, R, Tefferi, A, Solary, E
Publicado 2015

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

por Patnaik, M M, Wassie, E A, Padron, E, Onida, F, Itzykson, R, Lasho, T L, Kosmider, O, Finke, C M, Hanson, C A, Ketterling, R P, Komrokji, R, Tefferi, A, Solary, E
Publicado 2015

WHO-defined ‘myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations...

por Patnaik, M M, Lasho, T L, Finke, C M, Gangat, N, Caramazza, D, Holtan, S G, Pardanani, A, Knudson, R A, Ketterling, R P, Chen, D, Hoyer, J D, Hanson, C A, Tefferi, A
Publicado 2010

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response

por Begna, K. H., Kittur, J., Gangat, N., Alkhateeb, H., Patnaik, M. S., Al-Kali, A., Elliott, M. A., Hogan, W. J., Litzow, M. R., Pardanani, A., Hanson, C. A., Ketterling, R. P., Tefferi, A.
Publicado 2022

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3”

por Begna, K. H., Xu, X., Gangat, N., Alkhateeb, H., Patnaik, M. M., Al-Kali, A., Elliott, M. A., Hogan, W. J., Litzow, M. R., Hook, C. C., Wolanskyj-Spinner, A. P., Mangaonkar, A., He, R., Pardanani, A., Shah, M., Ketterling, R. P., Tefferi, A.
Publicado 2022

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies

por Padron, E, Garcia-Manero, G, Patnaik, M M, Itzykson, R, Lasho, T, Nazha, A, Rampal, R K, Sanchez, M E, Jabbour, E, Al Ali, N H, Thompson, Z, Colla, S, Fenaux, P, Kantarjian, H M, Killick, S, Sekeres, M A, List, A F, Onida, F, Komrokji, R S, Tefferi, A, Solary, E
Publicado 2015

Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa

por Ablashi, D, Chatlynne, L, Cooper, H, Thomas, D, Yadav, M, Norhanom, A W, Chandana, A K, Churdboonchart, V, Kulpradist, S A R, Patnaik, M, Liegmann, K, Masood, R, Reitz, M, Cleghorn, F, Manns, A, Levine, P H, Rabkin, C, Biggar, R, Jensen, F, Gill, P, Jack, N, Edwards, J, Whitman, J, Boshoff, C
Publicado 1999